Dekowski S A, Holtzman R B
Division of Neonatology, Northwestern University Medical School, Chicago, Illinois, USA.
Pediatr Clin North Am. 1998 Jun;45(3):549-72. doi: 10.1016/s0031-3955(05)70027-4.
Surfactant replacement therapy has been shown to be an effective and often life-saving treatment for newborn infants with respiratory distress syndrome (RDS). This article provides the clinician with an update regarding the various other applications of surfactant replacement therapy, as well as issues related to surfactant administration for the preparations approved for use in pediatric patients.
表面活性剂替代疗法已被证明是治疗新生儿呼吸窘迫综合征(RDS)的一种有效且常常能挽救生命的疗法。本文为临床医生提供了有关表面活性剂替代疗法其他各种应用的最新信息,以及与已批准用于儿科患者的制剂的表面活性剂给药相关的问题。